70 related articles for article (PubMed ID: 6443368)
1. Experimental assessment of the relative abuse liability of triazolam and pentobarbital.
Roache JD; Griffiths RR
NIDA Res Monogr; 1984; 55():106-10. PubMed ID: 6443368
[No Abstract] [Full Text] [Related]
2. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
Roache JD; Griffiths RR
J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
[TBL] [Abstract][Full Text] [Related]
3. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
Carter LP; Richards BD; Mintzer MZ; Griffiths RR
Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
[TBL] [Abstract][Full Text] [Related]
4. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects.
Kirk T; Roache JD; Griffiths RR
J Clin Psychopharmacol; 1990 Jun; 10(3):160-7. PubMed ID: 2198294
[TBL] [Abstract][Full Text] [Related]
5. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
[TBL] [Abstract][Full Text] [Related]
6. Zolpidem and triazolam in humans: behavioral effects and abuse liability.
Evans SM; Griffiths RR
NIDA Res Monogr; 1989; 95():431-2. PubMed ID: 2701312
[No Abstract] [Full Text] [Related]
7. Comparison of the behavioral effects and abuse liability of ethanol and pentobarbital in recreational sedative abusers.
Guarino JJ; Roache JD; Kirk WT; Griffiths RR
NIDA Res Monogr; 1989; 95():453-4. PubMed ID: 2701315
[No Abstract] [Full Text] [Related]
8. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
[TBL] [Abstract][Full Text] [Related]
9. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
Rush CR; Higgins ST; Bickel WK; Hughes JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1218-26. PubMed ID: 8450459
[TBL] [Abstract][Full Text] [Related]
12. Abuse liability of triazolam: experimental measurements in animals and humans.
Griffiths RR; Ator NA; Roache JD; Lamb RJ
Psychopharmacol Ser; 1987; 3():83-7. PubMed ID: 3823094
[No Abstract] [Full Text] [Related]
13. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
14. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
Hallam KT; Olver JS; McGrath C; Norman TR
Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
[TBL] [Abstract][Full Text] [Related]
15. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
Evans SM; Troisi JR; Griffiths RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
17. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers.
Mintzer MZ; Griffiths RR
Behav Pharmacol; 2005 Nov; 16(7):579-84. PubMed ID: 16170235
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
[TBL] [Abstract][Full Text] [Related]
19. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.
Smith RB; Kroboth PD; Folan MM; Kroboth FJ; Rosanske TW
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690
[TBL] [Abstract][Full Text] [Related]
20. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
Mintzer MZ; Griffiths RR
Drug Alcohol Depend; 1998 Dec; 53(1):49-66. PubMed ID: 10933340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
